Literature DB >> 20821267

The diagnosis of Cushing's syndrome.

Ty B Carroll1, James W Findling.   

Abstract

Spontaneous Cushing's syndrome is well known but unusual clinical disorder. Many of the clinical features (central weight gain, glucose intolerance, hypertension, muscle weakness) are seen in other common conditions. Recognition of patients with multiple features, features unusual for their age (i.e. early onset osteoporosis or hypertension), patients with features more specific to Cushing's syndrome (i.e. easy bruising, facial plethora, and violaceous striae), and patients with incidental adrenal mass or polycystic ovary syndrome should prompt an evaluation for cortisol excess. Late-night salivary cortisol, 1 mg overnight dexamethasone suppression testing, or 24 h urine free cortisol determination have excellent diagnostic characteristics and should be obtain in patients with suspected Cushing' syndrome. If this initial testing is abnormal, further evaluation should be directed by an endocrinologist experienced in the diagnosis and differential diagnosis of Cushing' syndrome.

Entities:  

Mesh:

Year:  2010        PMID: 20821267     DOI: 10.1007/s11154-010-9143-3

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  49 in total

1.  Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests.

Authors:  M Castro; P C Elias; A R Quidute; F P Halah; A C Moreira
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

Review 2.  Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses.

Authors:  Mohamed B Elamin; M Hassan Murad; Rebecca Mullan; Dana Erickson; Katherine Harris; Sarah Nadeem; Robert Ennis; Patricia J Erwin; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

Review 3.  The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.

Authors:  J Newell-Price; P Trainer; M Besser; A Grossman
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

4.  Lisch nodules in Cushing's disease.

Authors:  E A Bouzas; G Mastorakos; G P Chrousos; M I Kaiser-Kupfer
Journal:  Arch Ophthalmol       Date:  1993-04

5.  Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy.

Authors:  V Kyriazopoulou; A G Vagenakis
Journal:  J Clin Endocrinol Metab       Date:  1992-07       Impact factor: 5.958

6.  Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.

Authors:  Masao Omura; Jun Saito; Kunio Yamaguchi; Yukio Kakuta; Tetsuo Nishikawa
Journal:  Hypertens Res       Date:  2004-03       Impact factor: 3.872

7.  Central serous chorioretinopathy in endogenous hypercortisolism.

Authors:  E A Bouzas; M H Scott; G Mastorakos; G P Chrousos; M I Kaiser-Kupfer
Journal:  Arch Ophthalmol       Date:  1993-09

8.  The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.

Authors:  James W Findling; Hershel Raff; David C Aron
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

9.  Subclinical hypercortisolism among outpatients referred for osteoporosis.

Authors:  Iacopo Chiodini; Maria Lucia Mascia; Silvana Muscarella; Claudia Battista; Salvatore Minisola; Maura Arosio; Stefano Angelo Santini; Giuseppe Guglielmi; Vincenzo Carnevale; Alfredo Scillitani
Journal:  Ann Intern Med       Date:  2007-10-16       Impact factor: 25.391

10.  Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients.

Authors:  Marie-Laure Nunes; Stéphanie Vattaut; Jean-Benoît Corcuff; Alexandre Rault; Hugues Loiseau; Blandine Gatta; Nathalie Valli; Luc Letenneur; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2008-11-11       Impact factor: 5.958

View more
  18 in total

Review 1.  Cushing's syndrome: diagnosis and surveillance using salivary cortisol.

Authors:  Hershel Raff
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

2.  β-Hydroxy-β-methylbutyrate (HMB) prevents dexamethasone-induced myotube atrophy.

Authors:  Zaira Aversa; Nima Alamdari; Estibaliz Castillero; Maurizio Muscaritoli; Filippo Rossi Fanelli; Per-Olof Hasselgren
Journal:  Biochem Biophys Res Commun       Date:  2012-06-13       Impact factor: 3.575

Review 3.  Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology.

Authors:  Davide Gnocchi; Carlo Custodero; Carlo Sabbà; Antonio Mazzocca
Journal:  J Mol Med (Berl)       Date:  2019-04-05       Impact factor: 4.599

Review 4.  Consensus on diagnosis and management of Cushing's disease: a guideline update.

Authors:  Maria Fleseriu; Richard Auchus; Irina Bancos; Anat Ben-Shlomo; Jerome Bertherat; Nienke R Biermasz; Cesar L Boguszewski; Marcello D Bronstein; Michael Buchfelder; John D Carmichael; Felipe F Casanueva; Frederic Castinetti; Philippe Chanson; James Findling; Mônica Gadelha; Eliza B Geer; Andrea Giustina; Ashley Grossman; Mark Gurnell; Ken Ho; Adriana G Ioachimescu; Ursula B Kaiser; Niki Karavitaki; Laurence Katznelson; Daniel F Kelly; André Lacroix; Ann McCormack; Shlomo Melmed; Mark Molitch; Pietro Mortini; John Newell-Price; Lynnette Nieman; Alberto M Pereira; Stephan Petersenn; Rosario Pivonello; Hershel Raff; Martin Reincke; Roberto Salvatori; Carla Scaroni; Ilan Shimon; Constantine A Stratakis; Brooke Swearingen; Antoine Tabarin; Yutaka Takahashi; Marily Theodoropoulou; Stylianos Tsagarakis; Elena Valassi; Elena V Varlamov; Greisa Vila; John Wass; Susan M Webb; Maria C Zatelli; Beverly M K Biller
Journal:  Lancet Diabetes Endocrinol       Date:  2021-10-20       Impact factor: 32.069

Review 5.  Dynamic changes of views on the brain changes of Cushing's syndrome using different computer-assisted tool.

Authors:  Lu Gao; Lu Liu; Lin Shi; Yishan Luo; Zihao Wang; Xiaopeng Guo; Bing Xing
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

6.  Determination of nighttime salivary cortisol during pregnancy: comparison with values in non-pregnancy and Cushing's disease.

Authors:  Ludmilla Malveira Lima Lopes; Rossana Pulcineli Vieira Francisco; Marco Aurélio Knippel Galletta; Marcello Delano Bronstein
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

7.  Cushing's syndrome: Stepwise approach to diagnosis.

Authors:  Anurag R Lila; Vijaya Sarathi; Varsha S Jagtap; Tushar Bandgar; Padmavathy Menon; Nalini S Shah
Journal:  Indian J Endocrinol Metab       Date:  2011-10

8.  Network identification of hormonal regulation.

Authors:  Daniel J Vis; Johan A Westerhuis; Huub C J Hoefsloot; Ferdinand Roelfsema; Jan van der Greef; Margriet M W B Hendriks; Age K Smilde
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

9.  An N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess.

Authors:  Liz Bentley; Christopher T Esapa; M Andrew Nesbit; Rosie A Head; Holly Evans; Darren Lath; Cheryl L Scudamore; Tertius A Hough; Christine Podrini; Fadil M Hannan; William D Fraser; Peter I Croucher; Matthew A Brown; Steve D M Brown; Roger D Cox; Rajesh V Thakker
Journal:  Endocrinology       Date:  2013-12-03       Impact factor: 4.736

10.  β-Hydroxy β-methylbutyrate improves dexamethasone-induced muscle atrophy by modulating the muscle degradation pathway in SD rat.

Authors:  Kyung Kyun Noh; Ki Wung Chung; Yeon Ja Choi; Min Hi Park; Eun Ji Jang; Chan Hum Park; Changshin Yoon; Nam Deuk Kim; Mi Kyung Kim; Hae Young Chung
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.